Induced Pluripotent Stem Cells Market is anticipated to grow at a CAGR of 7.32% from 2022 to 2028
Global Induced Pluripotent Stem Cells Market research report provides comprehensive information on the market. It also includes in-depth information about Market #Drivers, Opportunities, Market Restraints, Market Growth #Challenges and Cumulative #Growth Analysis. Moreover, the report also provides an in-depth analysis of the Induced Pluripotent Stem Cells Market by identifying key players. The report also examines the #competitive landscape of the Induced Pluripotent Stem Cells Market industry and analyses its impact on the growth of this market over the next few years. The segmental analysis focuses on revenue and forecast for the period 2019-2028.
Request PDF Sample Copy of Report @ Global Induced Pluripotent Stem Cells Market
research report Sample
Axiom Market Research & Consulting™ added a report on Global
Induced Pluripotent Stem Cells Market which includes study on derived cell
type, product, process, application, end user, and geography. The Global
Induced Pluripotent Stem Cells Market was projected to grow at a CAGR of 7.32%
for the forecast period 2022 to 2028. The global market is estimated and
forecasted in terms of revenue (USD Million) generated by the Global Induced
Pluripotent Stem Cells Market.
Induced
Pluripotent Stem Cells Market are derived from skin or blood cells
that have been reprogrammed back into an embryonic-like pluripotent state that
enables the development of an unlimited source of any type of human cell needed
for therapeutic purposes. For example, iPSC can be prodded into becoming beta
islet cells to treat diabetes, blood cells to create new blood free of cancer
cells for a leukemia patient, or neurons to treat neurological disorders.
MARKET
DRIVERS
The factors such as growing investment in
basic level research, especially by research organizations and academic
institutes in the last few years has led to an increased understanding of the
fundamental pathways through which induced pluripotent stem cells market
implicated in disease development are either up or down-regulated. This leads
to more questions about how biology works, the cause of the diseases and
potential diagnoses and treatments. Induced pluripotent stem cells display a
particular gene expression signature that is similar to that of embryonic stem
cells (ESCs) and exhibit both pluripotency and the capacity of self-renewal.
In the recent years, the complexity of
products requested by researchers has grown and this suggests improvement in
understanding of the basic pathways and discovery of some new pathways. It is
important for manufacturers of research products to keep up with the latest
developments to cater to the ever-changing requirements of the life sciences
industry.
MARKET
OPPORTUNITY
Despite the presence of several large-scale
players as well as multiple regional companies in the global iPS cell market,
there are very limited companies that have a complete focus on being a provider
of life science reagents and products. Different manufacturers have different
product offerings and specializations, with most large companies combining
research products and reagents with equipment and in-vitro diagnostics tools.
Having a sole focus on this market ensures better quality of products, customer
loyalty and an established distribution network that can increase the
availability of the product across the globe.
The spending by companies on the research
and development pertaining to life sciences is expected to provide lucrative
prospects for growth. Companies investing in providing tools and products to
cater to the research requirements of several healthcare providers and research
institutes can expect to see stable returns.
MARKET
RESTRAINTS
The major disadvantage associated with
autologous stem cell transplants in cancer therapy is that cancer cells
sometimes also get collected, along with stem cells, which may further put it
back into the body during the therapy. These factors collectively likely to
restrain the market growth during the forecast period.
MARKET SEGMENTAL OVERVIEW
The global induced pluripotent stem cells market comprises of
different market segment like derived Cell Type, Product, Processes,
Application, End User and Geography.
Request
For Global Induced Pluripotent Stem Cells Market Report Customization
INDUCED PLURIPOTENT STEM CELLS MARKET
BY DERIVED CELL TYPES
·
Hepatocytes
·
Fibroblasts
·
Keratinocytes
·
Amniotic
Cells
INDUCED PLURIPOTENT STEM CELLS MARKET
BY PRODUCT
·
Instruments/Devices
·
Automated
Platforms
·
Consumables
And Kits And Services
INDUCED PLURIPOTENT STEM CELLS MARKET
BY PROCESSES
·
Manual
·
Automated
Buy
Global Induced Pluripotent Stem Cells Market Research Report
INDUCED PLURIPOTENT STEM CELLS MARKET
BY APPLICATION
·
Drug
Development And Discovery
·
Toxicity
Screening
·
Regenerative
Medicines
INDUCED PLURIPOTENT STEM CELLS MARKET
BY END USER
·
Hospitals
·
Research
Laboratories
·
Academic
Research
INDUCED PLURIPOTENT STEM CELLS MARKET
BY GEOGRAPHY
·
North
America
·
Europe
·
Asia
Pacific
·
rest
of the world
Have
a Question Ask to Analyst
MARKET KEY PLAYERS
·
Fujifilm
Holding Corporation
·
Astellas
Pharma Inc.
·
Fate
Therapeutics, Inc.
·
Bristol-Myers
Squibb Company
·
ViaCyte,
Inc.
·
Celgene
Corporation
·
Aastrom
Biosciences, Inc.
·
Acelity
Holdings, Inc.
·
StemCells,
Inc.
·
Japan
Tissue Engineering Co. Ltd.
·
Organogenesis
Inc.
RECENT
DEVELOPMENT:
June
2021: Thermo Fisher Scientific Inc. announced that
it has won six awards in the annual CMO Leadership Awards. The awards,
presented by Life Science Leader and Outsourced Pharma, recognize top contract
manufacturing partners as evaluated by biopharma and biotech companies. It is
estimated that this recognition anticipated to strengthen company footprints in
global market and leading to upsurge company growth in the upcoming years.
June
2020: The LumaCyte collaborated with Catalent who
are the global provider of advanced delivery technologies, development, and
manufacturing solutions for drugs, biologics, cell and gene therapies, and
consumer health products. This collaboration aided in expanding the company
stem cell technology product Radiance and its application.
Comments
Post a Comment